Myomo to Present at the 30th Annual ROTH Conference
March 05 2018 - 8:00AM
Business Wire
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a
commercial stage medical robotics company, today announced that it
will be presenting at the 30th Annual ROTH Conference in Dana
Point, CA on Monday, March 12th at 9:00 AM PT, Blue - Salon 2.
Chairman and Chief Executive Officer Paul R. Gudonis will be
presenting, as well as meeting with investors.
A webcast of the presentation will be available at the Investor
Relations page of the Company's website. The webcast and
presentation will be archived on the Company's website for 90 days
following the event.
About Myomo
Myomo, Inc. is a commercial stage medical robotics company that
offers expanded mobility for those suffering from neurological
disorders and upper limb paralysis. Myomo develops and markets the
MyoPro product line. MyoPro is a powered upper limb orthosis
designed to support the arm and restore function to the weakened or
paralyzed arms of patients suffering from CVA stroke, brachial
plexus injury, traumatic brain or spinal cord injury, ALS or other
neuromuscular disease or injury. It is currently the only marketed
device that, sensing a patient’s own EMG signals through
non-invasive sensors on the arm, can restore an individual’s
ability to perform activities of daily living, including feeding
themselves, carrying objects and doing household tasks. Many are
able to return to work, live independently and reduce their cost of
care. Myomo is headquartered in Cambridge, Massachusetts, with
sales and clinical professionals across the U.S. For more
information, please visit www.myomo.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180305005224/en/
For Myomo:ir@myomo.comorInvestor Relations:PCG
AdvisoryVivian Cervantes,
646-863-6274vivian@pcgadvisory.comorPublic
Relations:GreenoughRachel Robbins,
617-275-6521rrobbins@greenough.biz
Myomo (AMEX:MYO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Myomo (AMEX:MYO)
Historical Stock Chart
From Apr 2023 to Apr 2024